Clinical Trial Update: Safety and Preliminary Efficacy of Sequential Multiple Ascending Doses of Solnatide to Treat Pulmonary Permeability Oedema in Patients With Moderate-to-severe ARDS [Phase 2]

View source ↗

Summary

Phase 2 trial of solnatide in sequential dose escalation shows safety and preliminary efficacy signals for pulmonary permeability edema in patients with moderat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Distress Syndrome

Drugs mentioned

• Solnatide (solnatide)

Snippet

Sponsor: Apeptico Forschung und Entwicklung GmbH | Conditions: ARDS | Phase 2 | Status: COMPLETED